image
Pharvaris N.V. PHVS
Healthcare - Biotechnology - NASDAQ - NL
Watchlist
$ 20.35
-0.973 %
$ 1.1 B
Market Cap
-7.37
P/E
BALANCE SHEET
399 M ASSETS
137.70%
Growth Rates
1Year 137.70%
3Years 57.99%
5Years 136.10%
7Years 0.00%
10Years 0.00%
14.6 M LIABILITIES
-20.72%
Growth Rates
1Year -20.72%
3Years 40.21%
5Years 97.99%
7Years 0.00%
10Years 0.00%
384 M EQUITY
157.30%
Growth Rates
1Year 157.30%
3Years 58.87%
5Years 138.73%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Pharvaris N.V.
image
Current Assets 398 M
Cash & Short-Term Investments 392 M
Receivables 1.04 M
Other Current Assets 5.26 M
Non-Current Assets 843 K
Long-Term Investments 0
PP&E 456 K
Other Non-Current Assets 388 K
Current Liabilities 14.6 M
Accounts Payable 2.91 M
Short-Term Debt 195 K
Other Current Liabilities 11.5 M
Non-Current Liabilities 43.6 K
Long-Term Debt 43.6 K
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 391.2 161.8 209.4 98.6 20.3 5.4 4.8
Short Term Investments 0.3 0 0 0 0 0 0
Receivables 1.0 0.4 0.7 0.6 0.2 0 1.06 K
Inventory (0.3) 4.0 1.5 0.5 0 0 0
Other Current Assets 5.6 4.6 1.5 1.8 47.5 K 22.6 K 0
Total Current Assets 397.9 166.8 211.6 101.0 20.6 5.4 4.8
PP&E 0.5 0.6 0.4 48.5 K 12.9 K 0 0
Intangible Assets 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0
Other Long Term Assets 0 0 0 0 0 0 0
Other Assets 0 0 1 0 0 0 0
Total Assets 398.7 167.7 212.1 101.1 20.6 5.4 4.8
LIABILITIES
Accounts Payable 2.9 6.0 2.1 0.7 0.5 0.2 60.5 K
Short Term Debt 0.2 0.2 99.4 K 0 0 0 0
Other Current Liabilities 11.1 10.9 (2.5) 4.5 1.4 0.2 77.4 K
Total Current Liabilities 14.6 18.2 7.0 5.3 1.9 0.5 0.1
Long Term Debt 43.6 K 0.2 0.2 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 0
Other Liabilities 0 0 6.8 0 0 0 0
Total Liabilities 14.6 18.5 7.1 5.3 1.9 0.5 0.1
EQUITY
Common Stock 6.3 4.1 4.0 0.2 0.1 0.1 0.1
Retained Earnings (265.9) (164.2) (87.6) (44.5) (18.5) (10.4) (6.1)
Other Accumulative Comprehensive Income/Loss 27.9 20.2 9.8 2.0 0.4 0.3 0.2
Total Equity 384.0 149.3 205.0 95.8 18.7 5.0 4.7
Total Liabilities and Equity 398.7 167.7 212.1 101.1 20.6 5.4 4.8
SHARES OUTSTANDING
Common Shares Outstanding 38.4 33.6 30.4 30.5 4.8 31.8